Stevens Raymond C Insider Trades

Insider Trading History

Track insider trading activity for Stevens Raymond C. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Danaher
Danaher DHR
Director
Holding Value $2.46M 13,728 shares
Last Trade
May 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$385k 2,379 shares
$161.91
$178.97
Danaher
Danaher DHR
Director
Holding Value $1.3M 7,246 shares
Last Trade
Apr 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.3k 199 shares
$177.25
$178.97
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF EXECUTIVE OFFICER
Holding Value $63.9M 1,401,593 shares
Last Trade
Mar 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29.4M 582,447 shares
$50.46
$45.61
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF EXECUTIVE OFFICER
Holding Value $52.1M 1,141,376 shares
Last Trade
Mar 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.37M 53,454 shares
$63.04
$45.61
Danaher
Danaher DHR
Director
Holding Value $1.26M 7,047 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.6k 158 shares
$218.89
$178.97
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF EXECUTIVE OFFICER
Holding Value $83.2k 1,824 shares
Last Trade
Nov 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.3k 824 shares
$34.34
$45.61
Danaher
Danaher DHR
Director
Holding Value $1.23M 6,888 shares
Last Trade
Oct 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.5k 160 shares
$215.38
$178.97
Danaher
Danaher DHR
Director
Holding Value $1.2M 6,727 shares
Last Trade
Jul 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.5k 168 shares
$205.48
$178.97
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF EXECUTIVE OFFICER
Holding Value $54.5M 1,194,830 shares
Last Trade
Jul 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$329k 16,050 shares
$20.51
$45.61
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF EXECUTIVE OFFICER
Holding Value $55.2M 1,210,880 shares
Last Trade
Jul 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.84M 89,697 shares
$20.51
$45.61
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF EXECUTIVE OFFICER
Holding Value $45.6k 1,000 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.2k 1,000 shares
$24.15
$45.61
Danaher
Danaher DHR
Director
Holding Value $2.21M 12,361 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$282k 1,478 shares
$190.95
$178.97
Danaher
Danaher DHR
Director
Holding Value $1.17M 6,559 shares
Last Trade
Apr 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.5k 175 shares
$197.14
$178.97
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF EXECUTIVE OFFICER
Holding Value $51.7M 1,133,678 shares
Last Trade
Mar 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.4M 826,890 shares
$21.05
$45.61
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF EXECUTIVE OFFICER
Holding Value $51.1M 1,121,183 shares
Last Trade
Mar 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$297k 12,495 shares
$23.75
$45.61
Danaher
Danaher DHR
Director
Holding Value $1.14M 6,383 shares
Last Trade
Jan 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.8k 147 shares
$222.84
$178.97
Danaher
Danaher DHR
Director
Holding Value $1.12M 6,236 shares
Last Trade
Oct 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.9k 134 shares
$245.39
$178.97
Danaher
Danaher DHR
Director
Holding Value $1.09M 6,102 shares
Last Trade
Jul 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.6k 119 shares
$273.91
$178.97
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF EXECUTIVE OFFICER
Holding Value $22.3M 488,766 shares
Last Trade
Jun 12, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.8M 150,000 shares
$52.00
$45.61
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF EXECUTIVE OFFICER
Holding Value $36.2M 793,346 shares
Last Trade
Jun 12, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.8M 150,000 shares
$52.00
$45.61

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up